Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.  

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.  

Save Category as RSS Feed
Search results for "". Page 1 of 1, Results 1 to 4
Title Location Country
Reset
Regulatory Strategy Lead
Regulatory Strategy Lead Copenhagen, Hovedstaden, DK Nov 22, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark
Vice President, Global Medical Safety
Vice President, Global Medical Safety Copenhagen, Hovedstaden, DK Nov 16, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark
Global Value Evidence & Patient Insights Student Assistant
Global Value Evidence & Patient Insights Student Assistant Copenhagen, Hovedstaden, DK Nov 14, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark
Research Informatics Specialist
Research Informatics Specialist Copenhagen, Hovedstaden, DK Nov 12, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark